Camila Urzua Fresno

Camila Urzua Fresno

Auto-generated profile, based on publicly available information

Camila Urzua Fresno

Division of Cardiology, Peter Munk Cardiac Center, Ted Rogers Program in Cardiotoxicity Prevention and Department of Medical Imaging, University Health Network, University of Toronto, Toronto, Canada

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2022 in Radiology
Verified
Journal Article
Closed access
MAMatthew Aitken
Matthew Aitken
MCMichael Vinchill Chan
Michael Vinchill Chan
CFCamila Urzua Fresno
Camila Urzua Fresno
AFAshley Farrell
Ashley Farrell
NINayaar Islam
Nayaar Islam
KHKate Hanneman
Kate Hanneman
In a meta-analysis of 33 studies, cardiac MRI had higher sensitivity but similar specificity compared with fluorodeoxyglucose PET for diagnosis of cardiac sarcoidosis. Background There is limited consensus regarding the relative diagnostic performance of cardiac MRI and fluorodeoxyglucose (FDG) PET for cardiac sarcoidosis. Purpose To perform a systematic review a...

25 May 2023 in Radiology: Cardiothoracic Imaging
Verified
Journal Article
Closed access
TSTamar Shalmon
Tamar Shalmon
FHFaisal Mhd. Dib Hamad
Faisal Mhd. Dib Hamad
LJLaura Jimenez-Juan
Laura Jimenez-Juan
AKAnish Kirpalani
Anish Kirpalani
CFCamila M. Urzua Fresno
Camila M. Urzua Fresno
AYAndrew T Yan
Andrew T Yan
To compare the predictive value of different myocardial scar quantification thresholds using cardiac MRI for appropriate implantable cardioverter defibrillator (ICD) shock and mortality. In this retrospective, two-center observational cohort study, patients with ischemic or nonischemic cardiomyopathy underwent cardiac MRI prior to ICD implantation. Late gadolinium enhancement (LGE) was first determined visually and then quantified by blinded cardiac MRI readers using different SDs above the mean signal of normal myocardium, full-width half-maximum, and manual thresholding. The intermediate signal “gray zone” was calculated as the differences between different SDs. Among 374 consecutive eligible patients (mean age, 61 years ± 13 [SD]; mean left ventricular ejection fraction, 32% ± 14; secondary prevention, 62.7%), those with LGE had a higher rate of appropriate ICD shock or death than those without (37.5% vs 26.6%, log-rank P = .04) over a median follow-up of 61 months. In multivariable analysis, none of the thresholds for quantifying scar was a significant predictor of mortality or appropriate ICD shock, while the extent of gray zone was an independent predictor (adjusted hazard ratio per 1 g = 1.025; 95% CI: 1.008, 1.043; P = .005) regardless of the presence or absence of ischemic heart disease (P interaction = .57). Model discrimination was highest for the model incorporating the gray zone (between 2 SD and 4 SD). Presence of LGE was associated with a higher rate of appropriate ICD shock or death. Although none of the scar quantification techniques predicted outcomes, the gray zone both in infarct and nonischemic scar was an independent predictor and may refine risk stratification. Keywords: MRI, Scar Quantification, Implantable Cardioverter Defibrillator, Sudden Cardiac Death Supplemental material is available for this article. © RSNA, 2023

13 January 2020 in Current Cardiovascular Imaging Reports
Verified
Journal Article
Closed access
PDF file
CFCamila Urzua Fresno
Camila Urzua Fresno
TSTamar Shalmon
Tamar Shalmon
OAOscar Calvillo Argüelles
Oscar Calvillo Argüelles
BWBernd J. Wintersperger
Bernd J. Wintersperger
PTPaaladinesh Thavendiranathan
Paaladinesh Thavendiranathan